Tilray Brands, Inc. Stock-Based Compensation
Tilray Brands, Inc. (TLRY) reported Stock-Based Compensation of $45.94 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-28
- Tilray Brands, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-05-31 was $14.88M, a 143.93% increase year-over-year.
- Tilray Brands, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-02-28 was $13.72M, a 240.15% increase year-over-year.
- Tilray Brands, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-11-30 was $12.28M, a 69.73% increase year-over-year.
- Tilray Brands, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-08-31 was $5.05M, a 26.96% decline year-over-year.
- Tilray Brands, Inc. share-based payment arrangement, noncash expense for fiscal 2026 was $45.94M, a 89.14% increase from fiscal 2025.
- Tilray Brands, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $24.29M, a 23.54% decline from fiscal 2024.
- Tilray Brands, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $31.77M, a 19.77% decline from fiscal 2023.
- Tilray Brands, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $39.59M, a 10.00% increase from fiscal 2022.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | $14.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $28.61M derived: sum of 2 quarters · filed 2026-07-28 | $40.89M derived: sum of 3 quarters · filed 2026-07-28 | $45.94M 10-K · filed 2026-07-28 | |||
| 2026-02-28 | $13.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $26.01M derived: sum of 2 quarters · filed 2026-04-01 | $31.06M 10-Q · filed 2026-04-01 | $37.16M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-11-30 | $12.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $17.34M 10-Q · filed 2026-01-08 | $23.43M derived: sum of 3 quarters · filed 2026-07-28 | $27.47M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-08-31 | $5.05M 10-Q · filed 2025-10-09 | $11.15M derived: sum of 2 quarters · filed 2026-07-28 | $15.19M derived: sum of 3 quarters · filed 2026-07-28 | $22.42M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-05-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $10.13M derived: sum of 2 quarters · filed 2026-07-28 | $17.37M derived: sum of 3 quarters · filed 2026-07-28 | $24.29M 10-K · filed 2026-07-28 | |||
| 2025-02-28 | $4.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $11.27M derived: sum of 2 quarters · filed 2026-04-01 | $18.19M 10-Q · filed 2026-04-01 | $25.44M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-11-30 | $7.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $14.15M 10-Q · filed 2026-01-08 | $21.41M derived: sum of 3 quarters · filed 2026-07-28 | $29.46M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-08-31 | $6.92M 10-Q · filed 2025-10-09 | $14.17M derived: sum of 2 quarters · filed 2026-07-28 | $22.23M derived: sum of 3 quarters · filed 2026-07-28 | $30.43M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-05-31 | $7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $15.31M derived: sum of 2 quarters · filed 2026-07-28 | $23.51M derived: sum of 3 quarters · filed 2026-07-28 | $31.77M 10-K · filed 2026-07-28 | |||
| 2024-02-29 | $8.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08 | $16.26M derived: sum of 2 quarters · filed 2025-04-08 | $24.52M 10-Q · filed 2025-04-08 | $34.35M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-11-30 | $8.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10 | $16.46M 10-Q · filed 2025-01-10 | $26.29M derived: sum of 3 quarters · filed 2025-07-29 | $35.92M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-08-31 | $8.26M 10-Q · filed 2024-10-10 | $18.09M derived: sum of 2 quarters · filed 2025-07-29 | $27.72M derived: sum of 3 quarters · filed 2025-07-29 | $38.66M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-05-31 | $9.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $19.46M derived: sum of 2 quarters · filed 2025-07-29 | $30.40M derived: sum of 3 quarters · filed 2025-07-29 | $39.59M 10-K · filed 2025-07-29 | |||
| 2023-02-28 | $9.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $20.57M derived: sum of 2 quarters · filed 2024-04-09 | $29.77M 10-Q · filed 2024-04-09 | $38.73M derived: sum of 4 quarters · filed 2024-10-10 | |||
| 2022-11-30 | $10.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | $20.14M 10-Q · filed 2024-01-09 | $29.11M derived: sum of 3 quarters · filed 2024-10-10 | $38.46M derived: sum of 4 quarters · filed 2024-10-10 | |||
| 2022-08-31 | $9.19M 10-Q · filed 2024-10-10 | $18.16M derived: sum of 2 quarters · filed 2024-10-10 | $27.52M derived: sum of 3 quarters · filed 2024-10-10 | $41.11M derived: sum of 4 quarters · filed 2024-10-10 | |||
| 2022-05-31 | $8.97M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $18.32M derived: sum of 2 quarters · filed 2024-07-30 | $31.92M derived: sum of 3 quarters · filed 2024-07-30 | $35.99M 10-K · filed 2024-07-30 | |||
| 2022-02-28 | $9.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | $22.95M derived: sum of 2 quarters · filed 2023-04-10 | $27.02M 10-Q · filed 2023-04-10 | $32.96M derived: sum of 4 quarters · filed 2023-07-26 | |||
| 2021-11-30 | $13.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $17.67M 10-Q · filed 2023-01-09 | $23.61M derived: sum of 3 quarters · filed 2023-07-26 | ||||
| 2021-08-31 | $4.07M 10-Q · filed 2022-10-07 | $10.01M derived: sum of 2 quarters · filed 2023-07-26 | |||||
| 2021-05-31 | $5.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $17.35M 10-K · filed 2023-07-26 | |||||
| 2021-03-31 | $7.19M 10-Q · filed 2021-05-10 | ||||||
| 2021-02-28 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06 | $11.41M 10-Q · filed 2022-04-06 | |||||
| 2020-12-31 | $6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $29.72M 10-K · filed 2021-02-19 | |||||
| 2020-11-30 | $5.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-10 | $8.34M 10-Q · filed 2022-01-10 | |||||
| 2020-09-30 | $8.08M 10-Q · filed 2020-11-09 | $23.40M 10-Q · filed 2020-11-09 | |||||
| 2020-08-31 | $2.85M 10-Q · filed 2021-10-07 | ||||||
| 2020-06-30 | $7.65M 10-Q · filed 2020-08-10 | $15.32M 10-Q · filed 2020-08-10 | $24.86M derived: sum of 3 quarters · filed 2021-05-10 | $33.51M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2020-05-31 | $18.08M 10-K · filed 2022-07-28 | ||||||
| 2020-03-31 | $7.68M 10-Q · filed 2021-05-10 | $17.22M derived: sum of 2 quarters · filed 2021-05-10 | $25.86M derived: sum of 3 quarters · filed 2021-05-10 | $33.78M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | $9.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $18.18M derived: sum of 2 quarters · filed 2021-02-19 | $26.11M derived: sum of 3 quarters · filed 2021-02-19 | $31.84M 10-K · filed 2021-02-19 | |||
| 2019-09-30 | $8.64M 10-Q · filed 2020-11-09 | $8.31M 10-Q · filed 2019-11-13 | $16.57M derived: sum of 2 quarters · filed 2020-11-09 | $22.30M 10-Q · filed 2020-11-09 | $21.21M 10-Q · filed 2019-11-13 | $26.41M derived: sum of 4 quarters · filed 2021-02-19 | |
| 2019-06-30 | $7.92M 10-Q · filed 2020-08-10 | $7.58M 10-Q · filed 2019-08-13 | $13.66M 10-Q · filed 2020-08-10 | $12.89M 10-Q · filed 2019-08-13 | $17.77M derived: sum of 3 quarters · filed 2021-02-19 | $29.02M derived: sum of 4 quarters · filed 2021-02-19 | |
| 2019-05-31 | $21.95M 10-K · filed 2021-07-28 | ||||||
| 2019-03-31 | $5.74M 10-Q · filed 2020-05-11 | $5.31M 10-Q · filed 2019-05-15 | $9.85M derived: sum of 2 quarters · filed 2021-02-19 | $21.09M derived: sum of 3 quarters · filed 2021-02-19 | $26.69M derived: sum of 4 quarters · filed 2021-02-19 | ||
| 2018-12-31 | $4.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $15.36M derived: sum of 2 quarters · filed 2021-02-19 | $20.96M derived: sum of 3 quarters · filed 2021-02-19 | $20.99M 10-K · filed 2021-02-19 | |||
| 2018-09-30 | $11.24M 10-Q · filed 2019-11-13 | $16.85M derived: sum of 2 quarters · filed 2019-11-13 | $16.88M 10-Q · filed 2019-11-13 | $16.91M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $5.60M 10-Q · filed 2019-08-13 | $5.63M 10-Q · filed 2019-08-13 | $5.67M derived: sum of 3 quarters · filed 2020-03-02 | $5.70M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | $31.00K 10-Q · filed 2019-05-15 | $66.00K derived: sum of 2 quarters · filed 2020-03-02 | $101.00K derived: sum of 3 quarters · filed 2020-03-02 | $136.00K derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $70.00K derived: sum of 2 quarters · filed 2020-03-02 | $105.00K derived: sum of 3 quarters · filed 2020-03-02 | $139.00K 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $35.00K 10-Q · filed 2018-11-14 | $70.00K derived: sum of 2 quarters · filed 2018-11-14 | $104.00K 10-Q · filed 2018-11-14 | ||||
| 2017-06-30 | $35.00K 10-Q · filed 2018-08-29 | $69.00K 10-Q · filed 2018-08-29 | |||||
| 2016-12-31 | $94.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |